Publication:

Personal Genome Sequencing in Ostensibly Healthy Individuals and the PeopleSeq Consortium

Loading...
Thumbnail Image

Date

2016

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

MDPI
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Linderman, Michael D., Daiva E. Nielsen, and Robert C. Green. 2016. “Personal Genome Sequencing in Ostensibly Healthy Individuals and the PeopleSeq Consortium.” Journal of Personalized Medicine 6 (2): 14. doi:10.3390/jpm6020014. http://dx.doi.org/10.3390/jpm6020014.

Abstract

Thousands of ostensibly healthy individuals have had their exome or genome sequenced, but a much smaller number of these individuals have received any personal genomic results from that sequencing. We term those projects in which ostensibly healthy participants can receive sequencing-derived genetic findings and may also have access to their genomic data as participatory predispositional personal genome sequencing (PPGS). Here we are focused on genome sequencing applied in a pre-symptomatic context and so define PPGS to exclude diagnostic genome sequencing intended to identify the molecular cause of suspected or diagnosed genetic disease. In this report we describe the design of completed and underway PPGS projects, briefly summarize the results reported to date and introduce the PeopleSeq Consortium, a newly formed collaboration of PPGS projects designed to collect much-needed longitudinal outcome data.

Description

Research Data

Keywords

personal genome sequencing, return of results, population screening, genomics

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories